# VitalScan MCG Rule-out Multi-centre Pivotal Study - UK

> **NCT02921438** · — · COMPLETED · sponsor: **Creavo Medical Technologies Ltd** · enrollment: 756 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** VitalScan Magnetocardiograph

## Key facts

- **NCT ID:** NCT02921438
- **Lead sponsor:** Creavo Medical Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-06
- **Primary completion:** 2018-12-14
- **Final completion:** 2019-02-28
- **Target enrollment:** 756 (ACTUAL)
- **Last updated:** 2019-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02921438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02921438, "VitalScan MCG Rule-out Multi-centre Pivotal Study - UK". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02921438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*